Refining the Feebris value proposition to meet NHS needs

Feebris’ mission is to bring AI-powered diagnostics and accelerated treatment to every household around the globe, beginning with the most vulnerable communities.

Overview:

• AI-guided tools support carers to capture and share health measurements far more accurately than traditional non-AI alternatives, enabling more targeted and earlier care for vulnerable patients.
• Their intuitive mobile application collates the AI-captured data to triage patients according to clinically validated risk frameworks and provides escalation recommendations, upskilling the existing workforce and improving patient outcomes.
• The mobile-based software platform is designed such that all users (clinical or non-clinical) may confidently detect and triage deterioration without the need for clinical training. It focuses on preventative healthcare, with check-ups conducted in the community setting and results distributed to primary care professionals.
• The platform has two main components:
  • Mobile application which enables carers, health care assistants, nurses, general/duty managers, or unskilled volunteers to collect clinically accurate patent data measurements in an intuitive way.
  • A web-based dashboard for doctors, nurses and carers to view patient check-ups from any location, with high-risk results highlighted for ease of identification.
• The earliest use of Feebris took place in India, where their remote monitoring technology was applied to paediatric respiratory care in urban slum environments.
• After expanding to the UK, Feebris’ ability to mobilise quickly and adapt to new demands was pivotal in the pandemic response, and their technology was implemented in care homes across London from March 2020. They enabled reliable and highly accurate remote monitoring of residents while homes were closed to the public, minimising traffic within homes and reducing the number of contacts per resident.
• Feebris now has a presence in 30 care homes in North East London, and within these homes has demonstrated significant reductions in incidents, hospital conveyances and blue calls. Beyond London, Feebris maintains and is developing strong partnerships, including:
  • Surrey Heartlands for paediatric home monitoring
  • Northumbria for district nursing care
  • Cheshire CCG for care home monitoring
  • A number of other private contracts

Feebris give carers additional skills and helps spread the workload. During the Covid-19 pandemic, two of our nurses were at high risk, so our senior carers were able to step-in and take observations.

– Care Home Manager

Accelerator support:

• Feebris’ NHS Navigator and DigitalHealth.London team supported the company in better understanding the complex NHS structure, funding streams, terminology, and national guidelines and requirements for digital health companies entering the NHS.
• The Accelerator programme supported Feebris in developing, refining and testing their value proposition for an AI-driven remote patient monitoring solution to fit NHS needs. This support was done through a series of workshops and one-to-one sessions with value proposition experts in the NHS, along with their NHS Navigator.
• Through the DigitalHealth.London Generator workshops and guidance from their NHS Navigator, Feebris were supported in identifying their tier on the NICE Evidence Standards Framework and to establish the research requirements to demonstrate efficacy and return on investment. They were also supported in performing a gap analysis on their current evidence based on the NICE Framework and establish an evidence generation strategy and future academic priorities.

It helps to reduce the stress and anxiety of the resident; reassures staff they are making the right decisions and helps us to articulate information to the GP.

– Nursing Home Manager

Key impacts of the product:

• With a chronic shortage of clinical professionals, Feebris powers the virtual ward round by allowing clinicians to reach into the community and view highly accurate health data insights without leaving the clinic.
• Feebris’ AI-driven remote patient monitoring technology provides a significant increase in accuracy and minimisation of bias in the measurement of vital signs. Research conducted by Feebris showed that their use of AI has improved the accuracy of measurements, reducing errors in readings from 23% to less than 1%, and false alarms from one in six (16%) to less than 2%.
• The accuracy of Feebris allows for high levels of trust from clinicians, and by accepting Feebris as a physician’s assistive tool, 71% of GPs reported improvements in flexible working and allocation of resources. This coupled with a 30% reduction in care home incidents requiring GP call-outs has helped to reduce the workload of NHS doctors while simultaneously upskilling carers and other health professionals.  

Feebris is a great tool supporting more patient centred care. It has provided timely data to inform clinical decision making in my practice and reduced A&E admissions as result.

– General Practitioner

Key successes so far:

• Feebris has been inducted into the 2021 NHS Innovation Accelerator Cohort
• Recognised as one of the Top 100 UK Businesses Ready for Export by The Department of Trade and Investment
• Feebris has been included in the Top 50 most innovative MedTech and HealthTech companies by Business Cloud.
• Published a series of case studies and podcasts demonstrating the efficacy and benefits of Feebris’ AI-driven RPM solution for patients.
• Selected for Techforce19’s Cohort One to deliver remote patient monitoring services to care homes in North East London.

Feebris is currently one of twenty SMEs on the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.